Data: 08/08/2026
Total encontrado: 12
1/12US=9 / Quimioterapia
Lambert JD, Yang CS. Tea and its constituents: green tea and its constituents: protection against DNA damage and carcinogenesis. In: Knasmüller S, DeMarini DM, Johnson I, Gerhäuser C. Chemoprevention of cancer and DNA damage by dietary factors. Weinheim: Wiley-VCH, 2009. p. 595-609. ISBN 978-3-527-32058-5.

CHA; CHA VERDE; DANOS NO DNA; CARCINOGENESE; CANCER; POLIFENOIS


2/12US=66 / Biol/Mol
Diehl MC, Elmore LW, Holt SE. Telomere dysfunction and the DNA damage response. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 87-125. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

TELOMERE DISFUNCAO E RESPOSTA A DANOS DO DNA; TELOMERO PROTEINAS DE LIGACAO; MANUTENCAO DOS TELOMEROS; DISFUNCAO; DANOS NO DNA; INSTABILIDADE GENOMICA


3/12US=66 / Biol/Mol
Shimamoto A, Aoki E, Sera AM, Tahara H. Protocol II: importance and methods of telomere G-tail length quantification. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 337-50. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

PROTOCOLO II; QUANTIFICACAO DOS TELOMEROS DE COMPRIMENTO G-TAIL; COMPRIMENTO TOLOMERE; G-TAIL TELOMERO HPA; TELOMERO - A LIGACAO AS PROTEINAS; DANOS NO DNA; APOPTOSE; PENT; T-OLA; PREMATURA SINDROME DE ENVELHECIMENTO; RELACIONADA COM A IDADE DOENCA


4/12US=85 / Biol/Mol
Park YK, Lee SH, Park E, Kim JS, Kang MH. Changes in antioxidant status, blood pressure, and lymphocyte DNA damage from grape juice supplementation. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 385-90. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

SUCO DE UVA; ANTIOXIDANTE; PRESSAO ARTERIAL; DANOS NO DNA; CONTROLADO POR PLACEBO


5/12US=101 / Câncer
Hiraku Y, Kawanishi S. Immunohistochemical analysis of 8-nitroguanine, a nitrative DNA lesion, in relation to inflammation-associated carcinogenesis. In: Kozlov SV, editor. Inflammation and cancer: methods and protocols. volume 2, molecular analysis and pathways. New York: Humana Press, 2009. p. 3-14. (Methods in Molecular Biology, 512) ISBN 978-1-60327-529-3.

8-NITROGUANINE; INFLAMACAO; CANCER; REATIVAS ESPECIES DE NITROGENIO; DANOS NO DNA; ANTICORPO; IMUNO-HISTOQUIMICA


6/12US=58 / Câncer
Krämer A. Centrosomes in checkpoint responses. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 53-67. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6.

CENTROSSOMAS NAS RESPOSTAS CHECKPOINT; CENTROSSOMA; DANOS NO DNA; CHECK-POINT; CHK1; PERICENTRIN; MICROCEFALINA; CDC25; SINDROME SECKEL; MICROCEFALIA; AMPLIFICACAO CENTROSSOMA; CATASTROFE MITOTICA


7/12US=58 / Câncer
Lee MH, Yeung SCJ, Yang HY. Interplay of 14-3-3 family of proteins with DNA damage-regulated molecules in checkpoint control. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 69-80. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6.

FAMILIA DE PROTEINAS COM 14-3-3; DANOS AO DNA; RESPOSTA CHECKPOINT; 14-3-3; AKT; MDM2; P53; DANOS NO DNA


8/12US=58 / Câncer
Kaina B, Roos WP, Christmann M. DNA damage response and the balance between cell survival and cell death. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 95-108. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6.

DANOS NO DNA; SOBREVIVENCIA CELULAR; MORTE CELULAR; CHECKPOINTS; CICLO CELULAR; RESPOSTA A DANOS DO DNA; REPARACAO DO ADN; P53; APOPTOSE; RECEPTORES DE MORTE; FAS; CAIXA ELETRONICO; ATR; DROGAS ANTICANCER


9/12US=58 / Câncer
Eastman A. The importance of p53 signaling in the response of cells to checkpoint inhibitors. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 189-98. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6.

DANOS NO DNA; PARADA DO CICLO CELULAR; P53; P21; CICLINA B; CHK1 INIBIDORES; UCN-01; INIBIDORES DA TOPOISOMERASE II; ANALOGOS DE NUCLEOSIDOS


10/12US=58 / Câncer
Siddik ZH. Targeting p21-dependent pathways for cell death in cancer therapy. In: ___. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 199-213. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6.

DANOS NO DNA; P21; CICLINA DEPENDENTE DE QUINASE; G1 RESPOSTA CHECKPOINT; PARADA DO CICLO CELULAR; TRANSATIVACAO; PARADA DO CICLO GENE


11/12US=82 / Biol/Mol
Schulz WA. DNA damage and DNA repair. In: ___. Molecular biology of human cancers: an advanced student's textbook. New York: Springer, 2007. p. 47-70. ISBN 978-1-4020-6559-0.

DANOS NO DNA; REPARO DO DNA; EXCISAO DE BASES; REPARO POR EXCISAO DE NUCLEOTIDEOS; REPARACAO CROSSLINK; SUSCETIBILIDADE AO CANCER


12/12US=47 / Biol/Mol
Coleman WB. An overview of nucleic acid chemistry, structure, and function. In: Coleman WB, Tsongalis GJ. Molecular diagnostics: for the clinical laboratorian. 2ª ed. Totowa: Humana Press, 2006. p. 13-24. ISBN 1-58829-356-4.

DIAGNOSTICO MOLECULAR; ACIDOS NUCLEICOS. ESTRUTURA; ACIDOS NUCLEICOS. FUNCAO; BIOLOGIA MOLECULAR; NATUREZA QUIMICA DO DNA; ESTRUTURA DO DNA; GENOMA HUMANO; ORGANIZACAO GENOMICA DO DNA; FUNCAO DO DNA; NATUREZA QUIMICA DO RNA; RNA. ESTRUTURA; RNA. FUNCAO; DANOS NO DNA; MUTAGENESE